[Infection of the central nervous system by Epstein-Barr virus: clinical manifestations and prognosis]
- PMID: 35014019
- PMCID: PMC11500028
- DOI: 10.33588/rn.7402.2021406
[Infection of the central nervous system by Epstein-Barr virus: clinical manifestations and prognosis]
Abstract
Introduction: The role of Epstein-Barr virus (EBV) in central nervous system (CNS) infections is not fully resolved. We wanted to describe the clinical manifestations of patients with EBV infection in cerebrospinal fluid.
Patients and methods: We reviewed the clinical records of all adult patients EBV PCR-positive in cerebrospinal fluid, without lymphoproliferative disease, during 2004 to 2020.
Results: We identified 27 patients, 22 (81.5%) were men, and median age was 54 years. Twenty-three (82.1%) patients were immunosuppressed, 16 HIV-positive. In 15 (55.6%) patients coinfection with another microorganism was diagnosed and in 12 (44.4%) patients it was detected as the only pathogen. Of the 12 patients, three (25%) was immunocompetent patients, one had Guillain Barre syndrome (GBS), another had disseminated multiphasic encephalitis, and another had lymphocytic meningitis; 9 (75%) immunosuppressed, 7 HIV-positive, 4 had encephalitis that resolved without sequelae and 4 had encephalopathy, two HIH-positive had moderate cognitive impairment as a sequela.
Conclusions: In our study, EBV produced encephalitis, meningitis, polyradiculomyelitis and GBS, mainly in immunosuppressed patients. In more than half of the cases, it is associated with other pathogens where the role of EBV is unclear. In immunocompetent patient, the infection can be serious and leave sequelae and in HIV-positive patients with encephalopatic involvement without encephalitis, the neurological damage could be greater, so we consider it of interest to carry out studies to evaluate the prognosis as well as the role of antivirals in the evolucion of these clinical pictures.
Title: Infección del sistema nervioso central por el virus de Epstein-Barr: manifestaciones clínicas y pronóstico.
Introducción. El papel del virus de Epstein-Barr (VEB) en las infecciones del sistema nervioso central no siempre está claro. Nuestro objetivo fue describir las manifestaciones clínicas y la evolución de los pacientes con detección del VEB en el líquido cefalorraquídeo (LCR). Pacientes y métodos. Se revisaron las historias clínicas de todos los pacientes adultos con detección del VEB en el LCR por reacción en cadena de la polimerasa diagnosticados desde 2004 hasta 2020 sin enfermedad linfoproliferativa. Resultados. Se diagnosticó a 27 pacientes, 22 (81,5%) hombres, con una mediana de 54 años; 23 (82,1%) pacientes eran inmunodeprimidos, 16 positivos para el virus de la inmunodeficiencia humana (VIH). En 15 (55,6%) pacientes, el VEB se detectó en coinfección con otro microorganismo, y en 12, como único patógeno. De los 12 pacientes, tres (25%) eran inmunocompetentes, uno presentó un síndrome de Guillain-Barré, otro una encefalitis diseminada multifásica y otro una meningitis linfocitaria; y nueve (75%) inmunodeprimidos, de los que cuatro presentaron encefalitis que se resolvieron sin secuelas, y cuatro encefalopatía, dos de ellos positivos para el VIH, que presentaron secuelas (deterioro cognitivo moderado). Conclusiones. En nuestro estudio, el VEB produjo cuadros de encefalitis, meningitis, polirradiculomielitis y SGB, principalmente en inmunodeprimidos. En más de la mitad de los casos se asocia a otros patógenos, en donde el papel del VEB no está claro. En inmunocompetentes, las infecciones pueden ser graves y dejar secuelas, y en pacientes con VIH con encefalopatía sin encefalitis, el daño neurológico podría ser mayor, por lo que consideramos de interés realizar estudios que evalúen el pronóstico y el papel de los antivirales en la evolución de estos cuadros clínicos.
Conflict of interest statement
Conflicto de intereses: No declarado.
Similar articles
-
Clinical significance of Epstein-Barr virus in the cerebrospinal fluid of immunocompetent patients.Clin Neurol Neurosurg. 2021 Mar;202:106507. doi: 10.1016/j.clineuro.2021.106507. Epub 2021 Jan 19. Clin Neurol Neurosurg. 2021. PMID: 33493883
-
Epstein-Barr virus infections of the central nervous system.Intern Med. 2003 Jan;42(1):33-40. doi: 10.2169/internalmedicine.42.33. Intern Med. 2003. PMID: 12583615
-
Epstein-barr virus-associated encephalitis in a case-series of more than 40 patients.Wiad Lek. 2018;71(6):1224-1230. Wiad Lek. 2018. PMID: 30267504
-
Lessons from Epstein-Barr virus DNA detection in cerebrospinal fluid as a diagnostic tool for EBV-induced central nervous system dysfunction among HIV-positive patients.Biomed Pharmacother. 2022 Jan;145:112392. doi: 10.1016/j.biopha.2021.112392. Epub 2021 Nov 12. Biomed Pharmacother. 2022. PMID: 34781140 Review.
-
Epstein-Barr virus and human herpesvirus type 8 infections of the central nervous system.Herpes. 2004 Jun;11 Suppl 2:120A-127A. Herpes. 2004. PMID: 15319099 Review.
Cited by
-
Severe Epstein-Barr virus encephalitis with peripheral nerve damage: A case report.Medicine (Baltimore). 2024 Dec 13;103(50):e40804. doi: 10.1097/MD.0000000000040804. Medicine (Baltimore). 2024. PMID: 39686449 Free PMC article.
References
-
- Carbone A, Gloghini A, Dotti G. EBV-associated lymphoproliferative disorders:classification and treatment. Oncologist. 2008;13:577–85. - PubMed
-
- Yanagisawa K, Tanuma J, Hagiwara S, Gatanaga H, Kikuchi Y, Oka S. Epstein-Barr viral load in cerebrospinal fluid as a diagnostic marker of Central Nervous System involvemetn of AIDS-related lymphoma. Intern Med. 2013;52:955–9. - PubMed
-
- Polilli E, Sozio F, Mazzotta E, Consorte A, Di Masi F, Agostinone A, et al. Rapidly progressive and fatal EBV-related encephalitis in a patien with advanced HIV-1 infection at presentation:a case report and review of the literature. New Microbiol. 2010;33:275–80. - PubMed
-
- Lee GH, Kim J, Kim HW, Cho JW. Clinical significance of Epstein-Barr virus in the cerebrospinal fluid of immunocompetent patients. Clin Neurol Infect. 2021;202:106507. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources